Fairmount Partners Advises Pinnacle 21, a Leader in Data Standardization Software for Pharmaceutical Clinical Data, in its Pending Acquisition by Certara

Transaction accretive to Certara’s revenue, adjusted EBITDA, and adjusted EPS, subject to closing PRINCETON, NJ – August 5, 2021 – Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced it has signed a definitive agreement to acquire Pinnacle 21 for $310 million in cash and stock.  Pinnacle 21’s software tools are used to […]